Cocaine Dependence Clinical Trial
Official title:
The Impact of Neuropsychological Rehabilitation on Cocaine/Crack Dependents: a Placebo-controlled Study Using Cognitive Tests and Functional Magnetic Resonance Imaging.
Cocaine/Crack Dependence has been associated with neuropsychological impairments mainly in executive functions and decision-making, which are predominantly managed by the prefrontal cortex (PFC) in the brain. However, none study in Neuropsychological Rehabilitation (NR) has been done in order to remediate the executive functioning in this population. The aim of this research is to investigate the impact of neuropsychological intervention based on the stimulation of cognitive functions such as attention, planning, organization, logical reasoning, executive functioning, and decision making. For this research it will be proposed interventions through motivational strategies and board games, especially chess because it has been associated with PFC functioning, since it is a game which requires complex cognitive abilities, such as: inhibitory control, mental flexibility, sustained attention, future planning and decision-making. There will be two groups of patients with cocaine/crack dependence (n = 56), one with NR (group A, n = 28) and another without NR (group B, n = 28). Group B will be submitted to the placebo intervention. Both groups will be submitted to an extensive battery of neuropsychological tests and psychopathological rating scales before and after interventions. A sub-group will also be submitted to functional magnetic resonance imaging and biomarkers measures (BDNF and cortisol). The hypothesis is that group A will present a pronounced improvement not only on the neuropsychological test but also on the PFC functioning in neuropsychological functions compared to group B.
Cognitive Stimulation - The Motivational Chess (MC) was designed to stimulate executive
cognitive functioning. The idea of combining Motivational Interviewing (25) with chess game
was to stimulate discrepancy, motivation, and support self-efficacy. Volunteers will be
submitted to 10 sessions of 90 minutes, over three weeks (total 15 hours: 10 hours of chess
practice and 5 hours of motivational interviewing). At the beginning of each session the
participants will be divided into pairs and received a sheet containing the game rules (that
sheet worked as a kind of working memory aid). During the game practice, there will be a
therapist (coordinator) observing, helping, and motivating the participants for
goal-directed behaviors. The therapist interventions will be focused on patient's behavior,
analyzing if they know the game rules, are able to follow the rules, have visual perception
of the pieces, and use strategies considering short or long-term consequences. Another
relevant role of the therapist will be empathic with the patients and to help them deal with
their own resistance to change or to adapt to new situations.
The last 30 minutes of MC will be divided into three stages: 1) a short presentation on the
cognitive deficits due to CD (Giving Information); 2) participants will report their
impressions about their performance in chess linking it to real life situations such as
drug-related events, difficulty monitoring and directing behavior, controlling craving and
relapse (Developing Discrepancy); 3) discussions encouraging healthy decision making,
focusing on future and favorable real-life long-term behaviors, as opposed to immediate and
high risk behaviors (Supporting Self-Efficacy).
Control Group - The Active Control (AC) group will occur exactly on the same conditions of
the MC group. It consists of one hour of recreational activities to stimulate more basic
cognitive functions, such as simple attention (for example, to follow a simple sequence of
actions), motor coordination and visual functions. Ten activities were structured using
cardboard, paper, crayons, among others. In the last 30 minutes, there will be a
presentation also based on Motivational Interviewing, but limited to providing information
about basic cognitive functions (Giving Information) and promoting motivation to engagement
to the activities.
Procedures To enroll in this study, the participants must have a positive urine test for
cocaine and will answer to semi-structured clinical interviews (SCID and ASI-6) on the first
week. When the urine test becomes negative (mean in days: 9.48 ± 3.06), the pre assessment
will be applied (Neuropsychological and Psychopathological Assessment, Functional Magnetic
Resonance Imaging, Brain-derived neurotrophic factor levels and Cortisol levels) . Then the
participants will participate in 10 sessions of MC or AC for approximately 3 weeks. At the
end, if the urine test remains negative, the post assessment will be applied (about one
month of abstinence of cocaine use). The urine toxicology test will be used to have an
objective measure of recent use and abstinence.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04994821 -
tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
|
Phase 2 | |
Completed |
NCT01402492 -
Cocaine Use Reduction With Buprenorphine
|
Phase 2/Phase 3 | |
Completed |
NCT01601743 -
Exercise as a Behavioral Treatment for Cocaine Dependence
|
N/A | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT00880997 -
The Efficacy of Doxazosin for Cocaine Users
|
Phase 1 | |
Completed |
NCT00566969 -
Cocaine Withdrawal and Pharmacotherapy Response
|
N/A | |
Completed |
NCT00585520 -
Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
|
Phase 1 | |
Completed |
NCT00368290 -
Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior
|
Phase 2 | |
Completed |
NCT00322309 -
Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects
|
Phase 2 | |
Completed |
NCT00385801 -
Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
|
Phase 2 | |
Completed |
NCT00167245 -
Topiramate for Alcohol and Cocaine Dependence
|
Phase 2 | |
Completed |
NCT00842517 -
Long Term Maintenance of Drug Abstinence
|
Phase 1 | |
Not yet recruiting |
NCT05974202 -
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
|
Phase 2 | |
Completed |
NCT04411914 -
Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid
|
Phase 1 | |
Active, not recruiting |
NCT03266939 -
Rebalancing the Serotonergic System in Cocaine Dependence
|
Phase 1 | |
Completed |
NCT02563769 -
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
|
Phase 1 | |
Recruiting |
NCT06159387 -
Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts
|
Phase 4 | |
Terminated |
NCT02935101 -
Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants
|
Phase 2 | |
Completed |
NCT02018263 -
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
|
Phase 1 | |
Withdrawn |
NCT01406522 -
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics
|
Phase 2 |